IDYA 8-K 2026-11-03

IDEAYA Biosciences, Inc. (IDYA) 8-K dated 2026-11-03 — accession 0001193125-26-444225.

IDEAYA Biosciences, Inc. (IDYA) is a biotechnology company listed on NASDAQ.

IDYA: SECURITIES AND EXCHANGE COMMISSION

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported IDYA revenue for 2025-12-31 was $218.7M. Net income was -$113.7M. Revenue was up 3024.4% from 2024-12-31 to 2025-12-31. IDYA currently screens at market cap $2.96B.

Not investment advice. The IDYA SEC hub lists recent forms. The stock page is the research view.